At a biohacking conference this week, a biotech CEO dropped his pants and injected himself in the thigh with an experimental herpes treatment created by his company, leaving other biohackers worried.
UK’s biggest drugmaker, GlaxoSmithKline is poised to post record sales of over £30 billion for the first time, in Chief Executive Emma Walmsley’s first set of full-year results this week.
The largest genetic study is well underway, with scientists searching for inherited causes of insomnia in the DNA of 1,310,010 people.
Researchers have discovered a new cause of a rare condition knows as cblC, in which patients can’t process vitamin B12, leading to severe health problems. They report the condition, which they named “epi-cblC,” in patients from Europe and the United States.
A new approach to treatment for certain melanoma patients may lead to better results after surgery, a new study suggests.
A simple technique to gauge brain levels of a toxic protein could improve diagnosis and drug trials, to help in the quest to diagnose and treat Alzheimer’s disease.
In a world first, Chinese scientists have managed to give someone a new, perfectly compatible ear, freshly grown in the lab, using that person’s very own cells. This marks a huge step forward in the realm of regenerative medicine.
A biostatistician from the University of California is leading a research team that is uncovering how 716 human-specific DNA regions that work together to create the biological traits that differentiate us from other primates.